Moreover, immunohistochemistry examination revealed a downregulation in TGF-β1 renal tissue expression than in the DKD group, suggesting that celastrol may have a renoprotective effect by inhibiting miRNA-21 and miRNA-192 and their downstream targeting pathways. This evidence concerns the gene TGFB1 and diabetic kidney disease.